Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for Fascioscapulohumeral Muscular Dystrophy

Project: Research

StatusFinished
Effective start/end date1/08/1431/07/18

Funding

Rosetrees Trust: £60,000, Rosetrees Trust: £17,000

Project relations

Activities

Research outputs

ID: 37636592